BioNTech SE (BNTX) Change in Cash (2018 - 2025)

BioNTech SE has reported Change in Cash for 8 years, with the latest figure at -$2.8 billion in Q4 2025.

• Quarterly Change in Cash fell 2045.25% year-over-year to -$2.8 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.5 billion (down 16.5% YoY) and the FY2025 annual result came in at -$2.3 billion, down 13.77% from the prior year.
• Change in Cash eased to -$2.8 billion in Q4 2025 per BNTX's latest filing, from -$182.5 million in the prior quarter.
• Over five years, Change in Cash peaked at $5.0 billion in Q1 2022 and troughed at -$2.9 billion in Q1 2024.
• A 5-year average of $519.5 million and a median of $310.6 million in 2024 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2022 and 2025: Change in Cash soared 75234909.21% in 2022, then plunged 2045.25% in 2025.
• Over 5 years, Change in Cash stood at -$818.4 in 2021, then jumped by 75234909.21% to $615.7 million in 2022, then sank by 424.52% to -$2.0 billion in 2023, then soared by 107.28% to $145.4 million in 2024, then slumped by 2045.25% to -$2.8 billion in 2025.
• According to Business Quant data, Change in Cash over the past three periods registered -$2.8 billion, -$182.5 million, and $77.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.